Register for our S/EIS Fund

In this o2h ChaiTime we will host some of the most experienced Drug Hunters on the planet.

The panelists
Peter Hamley Chief Scientific Officer

Peter is a recognized industry leader in drug discovery, having spent 15 years at Sanofi, most recently as Global Head of External Innovation, Drug Discovery.

Karin Briner Vice President

is a medicinal chemist and Dr. Briner joined Novartis as Global Head of GDC in June 2011. She is a member of the senior leadership team of NIBR and has responsibilities for discovery chemistry research across all disease areas

Hemal Soni Head of Chemistry

Hemal is the Head of the PR&D at o2h discovery and is spearheading the chemistry team of ~200 chemists having led projects with many USA, UK, EU and Japanese biotech and pharma collaborators around the world.

Christopher Smith Senior Director

Chris is a medicinal chemist with over 20 years experience as a Entrepreneurial Drug Discovery leader with a track record of leading multiple drug discovery projects from hit identification to IND.

Sunil Shah CEO


Register for invitations

Email is not valid.
Thank you!